Compare ATAI & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATAI | EDN |
|---|---|---|
| Founded | 2018 | 1992 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2025 | 2007 |
| Metric | ATAI | EDN |
|---|---|---|
| Price | $4.18 | $25.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $15.88 | N/A |
| AVG Volume (30 Days) | ★ 6.6M | 132.1K |
| Earning Date | 05-11-2026 | 03-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,089,000.00 | N/A |
| Revenue This Year | N/A | $13.19 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.98 |
| Revenue Growth | ★ 1227.60 | N/A |
| 52 Week Low | $1.29 | $14.38 |
| 52 Week High | $6.73 | $38.10 |
| Indicator | ATAI | EDN |
|---|---|---|
| Relative Strength Index (RSI) | 51.59 | 37.95 |
| Support Level | $4.05 | $24.56 |
| Resistance Level | $4.30 | $32.50 |
| Average True Range (ATR) | 0.35 | 1.33 |
| MACD | -0.02 | -0.34 |
| Stochastic Oscillator | 31.36 | 18.41 |
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires, mainly for residential, commercial, industrial, and public service.